Astrana Health, Inc. (NASDAQ:ASTH) Receives $47.86 Consensus Target Price from Analysts

Astrana Health, Inc. (NASDAQ:ASTH) has been assigned a consensus recommendation of “Moderate Buy” from the nine ratings firms that are presently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $47.8571.

Several research firms have commented on ASTH. Truist Financial upped their price objective on shares of Astrana Health from $38.00 to $47.00 and gave the company a “buy” rating in a report on Thursday, May 14th. Robert W. Baird set a $45.00 price objective on shares of Astrana Health in a report on Friday, May 8th. Barclays upgraded shares of Astrana Health from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $37.00 to $50.00 in a research note on Tuesday, May 26th. TD Cowen increased their target price on Astrana Health from $45.00 to $50.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Finally, Needham & Company LLC lifted their price target on Astrana Health from $30.00 to $41.00 and gave the company a “buy” rating in a research report on Friday, May 8th.

Astrana Health Price Performance

Astrana Health stock opened at $35.56 on Friday. The business’s 50 day simple moving average is $41.63 and its 200 day simple moving average is $32.18. Astrana Health has a 12 month low of $18.08 and a 12 month high of $51.60. The company has a market cap of $1.98 billion, a price-to-earnings ratio of 58.30 and a beta of 0.89. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.20.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Thursday, May 7th. The company reported $0.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.45. Astrana Health had a return on equity of 9.22% and a net margin of 0.86%.The business had revenue of $965.10 million during the quarter, compared to the consensus estimate of $949.21 million. During the same period last year, the business posted $0.42 earnings per share. The business’s revenue for the quarter was up 55.6% on a year-over-year basis. Sell-side analysts forecast that Astrana Health will post 1.25 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the stock. Signaturefd LLC grew its holdings in shares of Astrana Health by 57.9% during the fourth quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock worth $26,000 after purchasing an additional 388 shares in the last quarter. GAMMA Investing LLC lifted its position in Astrana Health by 144.7% during the fourth quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock valued at $37,000 after purchasing an additional 871 shares during the last quarter. Strs Ohio bought a new stake in Astrana Health during the fourth quarter valued at approximately $40,000. Tower Research Capital LLC TRC grew its stake in Astrana Health by 323.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after buying an additional 3,517 shares in the last quarter. Finally, State of Wyoming purchased a new position in Astrana Health in the 2nd quarter worth approximately $132,000. Institutional investors own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.